Umbar Symbiotics India Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 12-07-2024
- Paid Up Capital ₹ 0.10 M
as on 12-07-2024
- Company Age 7 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 121.20%
(FY 2021)
- Profit 257.38%
(FY 2021)
- Ebitda 195.66%
(FY 2021)
- Net Worth 74.03%
(FY 2021)
- Total Assets 239.73%
(FY 2021)
About Umbar Symbiotics India
The Company is engaged in the Environment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Gautam Kumar, Navanath Pawar, and Sidharth Kumar serve as directors at the Company.
- CIN/LLPIN
U74999PN2017PTC172574
- Company No.
172574
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Sep 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Umbar Symbiotics India?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gautam Kumar  | Director | 18-Sep-2017 | Current |
| Navanath Pawar | Director | 18-Sep-2017 | Current |
| Sidharth Kumar | Director | 18-Sep-2017 | Current |
Financial Performance of Umbar Symbiotics India.
Umbar Symbiotics India Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 121.2% increase. The company also saw a substantial improvement in profitability, with a 257.38% increase in profit. The company's net worth Soared by an impressive increase of 74.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Umbar Symbiotics India?
In 2021, Umbar Symbiotics India had a promoter holding of 100.00%. The company had 1 Subsidiary and 2 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Atra Automotive Tyre Recyclers AssociationActive 2 years 3 monthsGautam Kumar, Navanath Pawar and 1 more are mutual person
- Padmagandha Surabhi FoundationActive 5 years 8 months
Gautam Kumar and Sidharth Kumar are mutual person
- Bta International India Private LimitedActive 6 years 1 month
Gautam Kumar and Sidharth Kumar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Umbar Symbiotics India?
Umbar Symbiotics India has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Umbar Symbiotics India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Umbar Symbiotics India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
